Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
Patients undergoing complex percutaneous coronary intervention (PCI) are at an increased risk of atherothrombotic complications. Although dual antiplatelet therapy is the mainstay of treatment for patients undergoing PCI with stent implantation, deciding its type and duration in complex PCI patients...
Saved in:
Main Authors: | Despoina-Rafailia Benetou, Charalampos Varlamos, Christos Pappas, Fotios Kolokathis, Dimitrios Alexopoulos |
---|---|
Format: | article |
Language: | EN |
Published: |
Radcliffe Medical Media
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/5b6f64e6a44a4cc9b162c9ac93c3aff0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Left Main Disease and Bifurcation Percutaneous Coronary Intervention: Focus on Antithrombotic Therapy
by: Charalampos Varlamos, et al.
Published: (2021) -
Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention
by: Dimitrios Alexopoulos, et al.
Published: (2020) -
Antithrombotic Therapy in Complex Percutaneous Coronary Intervention Patients Requiring Chronic Anticoagulation
by: Despoina-Rafailia Benetou, et al.
Published: (2021) -
Antithrombotic Therapy in Chronic Total Occlusion Interventions
by: Iosif Xenogiannis, et al.
Published: (2021) -
Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
by: Tamara García Camarero, et al.
Published: (2020)